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ABSTRACT
From our study, all three covid-19 vaccines have a similar proportion of adverse
reaction reports in which the patient had a history of allergies. However, the
proportion of life-threatening outcomes were lower for those with the Janssen
vaccine (0.62% hospitalization rate for Janssen versus 2.59% for Pfizer and 0.60%
death for Janssen versus 5.15% for Moderna). In terms of specific allergies,
patients with *cillin or sulfa allergies had the most adverse reactions to covid-19
vaccines, however, Janssen again had the lowest percentage of reported deaths
(1.39% for *cillin-related allergy deaths for Janssen versus 6.10% for Pfizer). In
terms of patient age and gender, females has 2.9x the number of adverse reactions
than males and a lower average age for reactions for the Pfizer and Moderna
vaccines. We feel this data could be used by individuals and medical professionals
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to assist in choosing a vaccine to maximize patient safety based on their allergy
history, age and gender.

Keywords: VAERS, SARS-COV2, Covid-19, Allergic Reactions

INTRODUCTION
According to the Centers for Disease Control and Prevention (CDC), "Any health
problem that happens after vaccination is considered an adverse event following
immunization. An adverse event can be a true adverse reaction, also known as a
side effect, that is related to the vaccine, or a coincidental event that happened
following vaccination." (Centers for Disease Control and Prevention, 2021).
Experts will attest that no vaccine is completely without risk, but the adverse
effects known to be caused by vaccines are usually short-lived and resolve on their
own or are treatable/reversible.
Common adverse effects may be observed where the vaccine injection was
delivered and may include pain, redness, and swelling. Systemic effects may
include tiredness, headache, muscle pain, chills, fever, nausea, and malaise. Other
serious effects such as swollen lymph nodes (lymphadenopathy), diarrhea and
vomiting have also been reported (Mayo Clinic, 2021).
The purpose of this manuscript is to explore the relationship between patients with
known allergies to reported adverse reactions with coronavirus vaccines.
In particular we examine the most common food, drug and environmental allergies
co-occurring with coronavirus vaccine adverse reactions to determine if any
relationship exists. We then investigate specific patient demographic information
such as age and gender to determine any statistical connection to coronavirus
vaccine adverse reactions.
The rest of this manuscript is organized as follows. Section 2 contains the literature
review that focuses on allergies, covid-19 vaccines, the Vaccine Adverse
Reporting System (VAERS) and known covid-19 vaccine allergies.

Section 3 is our research questions. Section 4 is the system design including
VAERS data, ETL and data cleaning. Section 5 is the experimental design. Section
6 provides the experimental results and discussion. Finally, Section 7 delivers the
conclusions, limitations and future directions.
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LITERATURE REVIEW
To address these challenges we investigate the relevant literature on allergies,
covid-19 vaccines, a system for reporting vaccine adverse effects and known
allergies to covid-19vaccines. We then present the research gaps that have
motivated this investigation.

Allergies
The term allergy is used to refer to an organism’s immune response to a certain
substance that is generally harmless for other individuals, that can cause a series
of symptoms in said organism. An allergy tends to manifest itself as a temporary
allergic reaction that is visible as a series of highly varied symptoms which
manifest as skin problems, (eczema, erythema, pruritus, etc.) bronchial problems
(bronchospasm), problems of the nasal mucus, eyes (conjunctivitis), the digestive
tract (diarrhea or vomiting) and even other organs of the body. It may also lead to
allergic diseases such as asthma, rhinitis or urticaria, to mention a few. In the most
severe cases, it may produce anaphylactic shock, a severe and generalised allergic
reaction that may even cause the patient’s death (Brown & Turner, 2015).There
are different mechanisms for the diagnosis of allergies, ranging from skin tests,
blood tests or genetic studies. With regard to treatment, current medical practice is
based on four fundamental pillars, which are patient education, allergen avoidance,
pharmacological intervention, and immunotherapy (Levin, 2018). Allergies may
be classified in multiple ways, although this work focuses more on the type of
substance that causes the allergy. In this connection, it is worth highlighting three
types of allergies: those caused by foods such as eggs or milk; those caused by
medicines such as antibiotics or anaesthetics; or those caused by environmental
agents such as dust mites or pollen. In general, the different studies conducted point
to a slow increase in the prevalence of allergies among the world’s population,
mainly those caused by food and especially in Western nations
(Tang & Mullins, 2017).

Covid-19 Vaccines
A vaccine is a drug product that stimulates the immune system offering protection
from an infectious disease and vaccination is the act of introducing a vaccine into
the body. An individual who is immune to a disease because they have been
vaccinated cannot get that disease and cannot spread it to others. In other words, if
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an individual is immune to a disease, they can be exposed to it without becoming
infected.
Covid-19 is known to be caused by a virus known as SARS-CoV-2 coronavirus
(Veronin et al., 2021). Prior to the development of vaccines to prevent covid-19,
the most effective way to prevent illness was to avoid exposure to the virus. To
date, three covid-19 vaccines are authorized by the U.S. Food and Drug
Administration (FDA) for emergency use: Pfizer/BioNtech, Moderna, and Janssen
(produced by Johnson and Johnson). Additional vaccines may receive
authorization in 2021.
An Emergency Use Authorization (EUA) allows the FDA to make medical
products available immediately. The EUA process differs from an established
FDA approval or clearance. Under an EUA the FDA makes a medical product,
such as a vaccine, available to the public based on the best available evidence,
forgoing all of the evidence necessary for official FDA approval or clearance.
When evaluating an EUA, medical experts carefully balance the potential risks and
benefits of the products based on the available data.
On December 11, 2020 the FDA issued an EUA for the Pfizer-BioNTech covid19 vaccine for individuals 16 years of age and older. On May 10, 2021 the FDA
expanded the EUA to include adolescents 12-15 years of age.
The Pfizer-BioNTech covid-19 vaccine is a messenger RNA (mRNA) type, which
uses a relatively new innovative formulation technology. Unlike attenuated
vaccines that introduce a weakened or inactivated virus into the body, the PfizerBioNTech mRNA vaccine delivers a tiny piece of genetic code from the SARS
CoV-2 virus to host cells in the body, essentially giving those cells instructions, or
blueprints, for making copies of the protein spikes protruding from the
coronavirus. These proteins stimulate an immune response by producing
antibodies and developing memory cells that provide protection if the body is
infected with the actual virus.
On December 18, 2020 a second vaccine for prevention of covid-19, manufactured
by ModernaTX, Inc, was authorized for emergency use by individuals 18 years of
age and older. Moderna is also an mRNA vaccine using the same technology as
Pfizer-BioNTech.
On February 27, 2021 the FDA issued an EUA for a third vaccine manufactured by
Janssen Biotech Inc, a subsidiary of Johnson and Johnson, for individuals 18 years
of age and older.
The Janssen covid-19 vaccine is known as a carrier vaccine, or viral vector vaccine
which uses a different approach than mRNA vaccines. Viral vector vaccines use a
modified version of a different virus, such as an adenovirus (the vector) to instruct
human cells to make the SARS CoV-2 virus spike protein, stimulating an immune
response that provides protection if the body is infected with the actual virus.
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In early April 2021 the CDC and FDA issued a joint recommendation for states to
pause the use of the Janssen covid-19 vaccine due to a rare, potentially serious,
blood clotting disorder among women ages 18 to 48, occurring 6-13 days after
vaccination. On April 23, 2021, the FDA ended its recommended pause on the
vaccine and added a warning label about the blood clotting disorder which cleared
the way to resume vaccinations. On July 12, 2021 the FDA announced a warning
of increased risk for GuillainBarré syndrome, a progressively damaging
neurological disorder that can lead to paralysis or death for males 50 years of age
or older that can occur within 14 days of vaccination (Rendall, 2021).
Given these specific age/gender combinations reacting adversely to coronavirus
vaccines, having accurate records of vaccine adverse reactions can help medical
professionals make informed vaccine-related decisions.
VAERS
The Vaccine Adverse Event Reporting System (VAERS) is one of the largest
government databases and is comprised of adverse event reports following
vaccination (Singleton et al., 1999). Established in 1990, VAERS functions as a
warning system to detect potential safety issues associated with vaccines. Anyone
can submit a report to VAERS and reports have come from a variety of sources:
healthcare professionals, health departments, vaccine manufacturers, and vaccine
recipients (patients and family members) if they experience any adverse events
after receiving a vaccine.
VAERS is co-administered by two agencies within the U.S. Department of Health
and Human Services (HHS); the Centers for Disease Control and Prevention
(CDC) and the U.S. Food and Drug Administration (FDA). The CDC and the FDA
analyze reports of adverse events that monitor health problems that may occur
following vaccination (Varricchio et al., 2004).
While reports to VAERS are voluntary, healthcare providers are strongly
encouraged to report any additional clinically significant adverse events following
vaccination, even if they are not sure if vaccination caused the event. However,
under certain conditions, healthcare providers are required by law to report to
VAERS after vaccination. Conditions include: 1)
Vaccine administration errors, whether or not associated with an adverse event
(AE), 2)
Serious AEs as defined by the FDA regardless of causality, which includes: death,
life-threatening, inpatient hospitalization or prolongation of existing
hospitalization, or any pre-specified event that occurs within a certain period after
vaccination.
According to the CDC, the number of VAERS reports submitted varies each year.
During 2011-2014, VAERS averaged around 30,000 reports annually, with 7%
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classified as serious (Shimabukuro et al., 2015). In 2019 VAERS received over
48,000 reports. About 85-90% of the reports described mild side effects such as
fever, arm soreness, or mild irritability. The remaining reports are classified as
serious, which means that the reported AE resulted in permanent disability,
hospitalization, prolongation of an existing hospitalization, life-threatening illness,
congenital deformity/birth defect or death. According to the CDC these events can
happen after vaccination, but are rarely caused by the vaccine.
Known Covid-19 Vaccine Allergies
In addition to adverse effects in general, allergic reactions have been documented
and may be categorized as non-severe or severe. Non-severe allergic reactions
include by pale or reddened irregular, elevated patches and severe itching (urticaria
or hives), swelling or wheezing within 4 hours of the vaccine. Severe allergic
reactions to the vaccine are rare and may occur within 15 minutes of getting
vaccinated. Most have occurred in people with a history of allergies and who had
previously experienced a severe and potentially life-threatening allergic reaction
known as anaphylaxis. Signs and symptoms of anaphylaxis include a sensation of
tightness in the throat which may cause the throat to close, or trouble breathing.
Other rare occurrences reported after covid-19 vaccination include blood clots in
younger women (thrombosis with thrombocytopenia syndrome (TTS)) after
Janssen injections. In addition, researchers are investigating the link between cases
of inflammation of the heart, known as myocarditis and pericarditis in adolescents
and young adults, occurring after mRNA vaccination.
A vaccine component known as polyethylene glycol (PEG) has been associated
with anaphylaxis. Currently, PEG is found in the mRNA vaccines from Pfizer and
Moderna. The Janssen vaccine does not contain PEG, however, it contains
polysorbate, which is known to cross-react with PEG. This means that if an
individual is sensitive to PEG, they may also be sensitive to polysorbate.
Given the hundreds of millions of vaccine doses administered, reports of AEs
following vaccination, including deaths, are considered rare and do not necessarily
mean that the vaccine directly caused the problem. Since covid19 vaccines are
relatively new, scientists and clinicians have more questions than answers about
the occurrence of allergic reactions. Research is ongoing to determine which
patients, particularly those with prior vaccine allergies, may be at greater risk of
adverse reactions to covid-19 vaccines.
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Research Gaps
From this review, there are no studies that specifically examine patient allergies
and their relationship to coronavirus vaccine adverse effects. Most studies have
focused on specific disease states resulting from a vaccine. Using historical patient
data, medical professionals can improve vaccine recommendations based on
specific patient factors.

RESEARCH QUESTIONS
Which covid-19 vaccine is associated with the fewest reported adverse reactions?
Adverse reactions can occur with just about any vaccine. Analyzing the impacts of
covid-19 vaccines can help the public make informed decisions. Which allergens
are most associated with patient deaths for the covid-19 vaccines?
For patients with certain allergies, which allergens are observed most often and
which vaccines are associated with these adverse effects. Answering this question
can help guide patients to selecting vaccines least likely to cause significant
adverse effects.
Are there patient demographic differences w.r.t. to the covid-19 vaccines and
allergic reactions?
How does age and gender affect vaccine adverse effects? We analyze the three
vaccines according to patient age and gender for life-threatening reactions.
Answering this question can help providers to best recommend a vaccine to
patients.
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SYSTEM DESIGN
To answer these research questions we created the TylerADE System as shown in
Figure 1.
Figure 1 - The TylerADE System

This system collects VAERS data: patient, symptom and vaccine data, before
cleaning it by removing excess whitespace and performing a spellcheck. The most
common food, drug and environmental allergies are then collected and used to
filter VAERS data and store it in a database. The database is then queried to look
for statistical relationships in the data.

EXPERIMENTAL DESIGN
For our study we used the Vaccine Adverse Event Reporting System (VAERS) 4
data from January 1 to March 30, 2021. VAERS data is stored in three tables of
Data, Symptoms and Vaccine. For our study there were 46,163 records for Data,
64,356 for Symptoms and 46,824 for Vaccine. Between the three tables there were
45,800 covid-19 vaccine records in common. Table 1 shows the breakdown of
VAERS records for each of the three covid-19 vaccines and the number of records
in which allergens were reported.

4

https://vaers.hhs.gov/index.html
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Total Records
20,296
20,180
5,324

Allergen
Records
13,683
9,422
4,227

Table 1: Covid-19 VAERS Records by Vaccine
For allergens we selected the most common food, drug and environmental
allergens (HealthLine, 2020; The Daily Meal, 2012; WebMD, 2021). For food
allergens we used egg, milk, peanut, soy, wheat, tree nuts, shellfish, fish, raw
fruits/vegetables and sesame (The Daily Meal, 2012). For drug allergies we used
*cillin (family of antibiotics, e.g.; penicillin, amoxicillin, etc.), tetracycline,
ibuprofen, naproxen, aspirin, sulfa drugs, chemotherapy drugs, cetuximab,
rituximab, abacavir, nevirapine, insulin, carbamazepine, lamotrigine, phenytoin,
atracurium, succinylcholine and vecuronium (WebMD, 2021). For environmental
allergies we used dustmites, pollen, pet dander, mold and smoke (HealthLine,
2020).
RESULTS AND DISCUSSION
To answer our research questions, we investigated the VAERS data for each of the
three covid-19 vaccines.
Which covid-19 vaccine is associated with the fewest reported adverse reactions?
To answer this research question we analyze the proportion of VAERS records in
which allergens were reported versus their totals for each of the three vaccines as
shown in Table 2.
From this data, Janssen had the highest proportion of adverse event reports where
an allergy co-occurred with 79.40%, followed by Moderna with 67.42% and Pfizer
with 46.69%.
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Records Allergen Pct

Hospitalized
Death Pct
Vaccine
Pct
Moderna 20,296
67.42%
2.38%
5.15%
Pfizer
20,180
46.69%
2.59%
2.70%
Janssen
5,324
79.40%
0.62%
0.60%
Table 2: Covid-19 Vaccine Record Counts and Reaction Severity
However, the presence of adverse reports does not address the reaction severity
such as mild versus life-threatening interactions. Looking at the life-threatening
reactions, 2.38% of adverse reactions for Moderna required hospitalization and
5.15% died whereas for Janssen 0.62% required hospitalization and 0.60% died.
Janssen had a larger percentage of adverse reaction reports, but many of the
reactions were not life-threatening.
There are a few unique circumstances that make these vaccines different and can
impact the distribution of adverse reactions. First and foremost is that all vaccines
are dosed in multidose vials. Therefore this forces a batch system type distribution,
limiting vaccinations to small groups of 5 or 10 individuals depending on the multidose vial. As such, vaccine distribution for such a limited resource make
distribution a group effort, and not an individual process. It is unclear how this
may, or may not, affect the reported adverse events.
Another confounding factor is the temperature at which the vaccine needs to be
stored. As the pandemic was unfolding, the Pfizer vaccine needed to be stored at a
temperature of -112 to -67 degree F. This limited the distribution of the Pfizer
vaccine to facilities that had the proper equipment. Some vaccine locations could
not properly store the vaccine, therefore introducing a selection bias into the
process, as many small and/or rural facilities elected not to distribute the Pfizer
vaccine. It is unclear how this affected the reported adverse events.
With the process of vaccination, or 2 vaccines for certain individuals, there is also
a concern that those individuals receiving only 1 of the 2 injections may not have
had sufficient vaccine to provide proper immunization.
To answer Research Question 1 of which vaccine is associated with the fewest
number of reported adverse reactions, the Pfizer vaccine had the fewest with
46.69%, however, Janssen had the fewest life-threatening reactions.
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Which allergens are most associated with patient deaths for the covid-19
vaccines?
To answer this research question we investigated common food, drug and
environmental allergens and their co-occurrence with the three vaccines. Table 3
lists the percentage of VAERS records in which a specific allergen was reported.
For presentation clarity we excluded allergens where none of the vaccines
exceeded 1.00% of adverse reports.
Vaccine
Egg Tree Nut Shellfish *cillin Aspirin Sulfa Pollen
Moderna 0.81%
0.93%
2.00% 11.49% 0.99% 9.66% 0.98%
Pfizer
0.74%
1.09%
2.06% 11.13% 1.21% 9.70% 0.99%
Janssen 1.02%
1.25%
1.77% 11.92% 0.95% 7.22% 1.54%
Table 3: lists the percentage of VAERS records with specific allergen
reported
From this data both the *cillin and Sulfa family of drugs had the highest proportion
of reported adverse reactions across all three vaccines. It was interesting to note
the similarity of proportion across all three vaccines. These numbers indicate that
for 11% and 9% of adverse reactions, *cillin and Sulfa drugs were present
respectively. While we do not possess data for allergy patients that did not have an
adverse reaction, the relative difference in reaction percentages is still a cause for
concern for those patients with *cillin and Sulfa allergies.
If we were to look at the occurrence of patient adverse records containing both
*cillin and Sulfa drugs, this combination accounted for 1.98% of Moderna
reactions, 1.95% for Pfizer and 1.75% for Janssen; much smaller by comparison.
Analyzing allergens through the prism of patient death for food, drug and
environment are Tables 4, 5 and 6 respectively. For presentation clarity we omitted
any allergen that did not have 30 or more occurrences per vaccine.
From this data for adverse reaction to *cillin drugs, 6.10% of Pfizer patients died
versus 1.39% for Janssen. Sulfa drugs showed a similar ordering with 4.70% of
Pfizer patients dying versus 0.66% for Janssen. The other notable findings were
for the antibiotic Tetracycline which shown a similar ordering with 6.56% of Pfizer
patients dying and Aspirin where 8.89% of Moderna and 5.26% of Pfizer patients
died. It does appear that Janssen is the safest of the three vaccines in contributing
to the fewest patient deaths across all allergens investigated.
These results stand in contrast to prior work in which there has been no generally
accepted research published of a link between drug allergies and vaccines adverse
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events (American College of Allergy, Asthma and Immunology, 2021; Blumenthal
et al., 2021).
Vaccine

Egg

Milk Peanut Shellfish

Moderna 2.70% 0.00% 2.13%
Pfizer
1.43% 2.78% 1.37%
Janssen 0.00%
NA 0.00%

Fish

2.92% 4.00%
2.58% 0.00%
1.33%
NA

Table 4: Covid-19 Vaccine Patient Deaths and Food Allergies

Vaccine

*cillin Tetracycline Ibuprofen Naproxen Aspirin

Moderna 3.94%
Pfizer
6.10%
Janssen 1.39%

4.71%
6.56%
NA

2.44%
3.28%
NA

2.78%
3.23%
NA

Sulfa

8.89% 2.50%
5.26% 4.70%
0.00% 0.66%

Table 5: Covid-19 Vaccine Patient Deaths and Drug Allergies

Vaccine
Moderna
Pfizer
Janssen

Dustmites Pollen Mold
2.22% 2.24% 0.00%
NA 2.15% 3.51%
NA 0.00% 0.00%

Table 6: Covid-19 Vaccine Patient Deaths and Environmental Allergies
Are there patient demographic differences w.r.t. to the covid-19 vaccines and
allergic reactions?
To answer this research question we analyze the three vaccines according to patient
age and gender for life-threatening reactions as shown in Table 7.
From this data the average age of patient adverse reactions for both Moderna and
Pfizer was 51.0 years versus 46.1 years for Janssen. The average age for adverse
reactions is a bit misleading. During the period of study, covid-19 vaccines were
eligible for patients 75 years or older, or had a compromised immune system, or
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had a substantial risk factor or were frontline healthcare workers. Because of the
skewness of data we cannot make patient age generalizations in the absolute
sense. Instead we can use the age-related data comparatively. This is to say
patients of 51.0 years are not in more danger, rather that Janssen appears to
affect younger patients more than other vaccines.
Also within the data females had 2.9x more reported adverse reactions than males.
This is a similarly unexpected result and could also be the result of skewed data
where more female healthcare workers were receiving the vaccine than male
counterparts. We do not have access to such data to know this definitively so we
will also use gender for comparative analysis.
If we were to focus on just *cillin and Sulfa drugs and their patient demographics
for adverse reactions, we would arrive at Tables 8 and 9 respectively.
Vaccine

Avg Age Male Female Hospitalized Died

Moderna
51.0 5,025 14,908
1,556 1,140
Pfizer
51.0 4,966 14,567
1,499 989
Janssen
46.1 1,540 3,740
110
54
Table 7: Covid-19 Vaccine Patient Demographics
Vaccine

Avg Age Male Female Hospitalized Died

Moderna
51.8 266 1,306
42
62
Pfizer
52.0 189
857
29
64
Janssen
49.9 111
392
2
7
Table 8: Covid-19 Vaccine Patient Demographics for *cillin Drugs

Vaccine

Avg Age Male Female Hospitalized Died

Moderna
52.6 127 1,189
37
33
Pfizer
52.5 100
809
28
43
Janssen
51.5
22
283
2
2
Table 9: Covid-19 Vaccine Patient Demographics for Sulfa Drugs
From this data patient age is roughly similar to that in Table 7. However vaccine
adverse effects appear to be affecting females in greater numbers, 4.5x for *cillin
and 9.2x for Sulfa drugs versus 2.9x for all allergens. This significant increase in
adverse effects for females is certainly interesting and should be studied further.
Patients with life-threatening reactions appear in a lower proportion.
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Looking deeper at age-related data, Tables 10 and 11 show the average patient ages
for adverse reactions for *cillin and Sulfa drugs respectively.
Vaccine

Male Female Hospitalized Died

Moderna 58.5
50.5
61.0 80.2
Pfizer
57.7
50.7
55.1 73.7
Janssen
48.3
50.4
72.5 73.3
Table 10: Covid-19 Vaccine Patient Demographics Average Age for
*cillin Drugs
Vaccine

Male Female Hospitalized Died

Moderna 59.6
51.9
61.4 75.7
Pfizer
55.1
52.2
57.4 79.1
Janssen
47.0
51.8
46.5 71.5
Table 11: Covid-19 Vaccine Patient Demographics Average Age for
Sulfa Drugs
From this data it would appear that females have adverse reactions at a younger
age for Moderna and Pfizer vaccines. However, for life-threatening reactions such
as hospitalization and death, ages track higher with the exception of Pfizer
hospitalization for *cillin, average age 55.1 years, and Janssen hospitalization for
Sulfa, average age 46.5 years.
To investigate these outliers further, we dived deeper into patient ages for lifethreatening reactions to *cillin and Sulfa drugs in Tables 12 and 13 respectively.
From this data we find that average ages for patient death are generally higher than
for patient hospitalizations, with the most notable exception for males and Sulfa
drugs where the average patient age with death as an outcome, occurs at younger
ages for the Moderna and Pfizer vaccines. Interestingly no male patient death or
hospitalization occurred with the Janssen vaccine for Sulfa drug allergies. Further,
we noted large average age differences across genders for Sulfa drug
hospitalizations for Moderna and Pfizer as well as *cillin drug hospitalizations for
Moderna.
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Vaccine Male Female Male Female
Moderna 68.3
56.9 77.9
83.1
Pfizer
53.0
55.5 71.4
74.9
Janssen
NA
72.5 68.4
85.5

Table 12: Covid-19 Vaccine Patient Ages for Life-Threatening Reactions
with *cillin Drugs
Vaccine Male Female Male Female
Moderna 81.4
58.3 68.9
77.6
Pfizer
77.0
56.7 76.2
80.4
Janssen
NA
46.5 NA
71.5
Table 13: Covid-19 Vaccine Patient Ages for Life-Threatening Reactions
with Sulfa Drugs

CONCLUSIONS, LIMITATIONS AND FUTURE DIRECTIONS
Using this data from a patient safety perspective, it would appear that Janssen has
the lowest proportion of life-threatening adverse reactions. In terms of specific
allergies, patients with *cillin or sulfa allergies had the most adverse reactions to
covid-19 vaccines, however, Janssen again had the lowest number of reported
deaths. In terms of patient age and gender, females has 2.9x the number of adverse
reactions than males and a lower average age for reactions for the Pfizer and
Moderna vaccines.
While this study relied on reported adverse events and not the universe of data (i.e.
patients receiving a vaccine without complication or all patients with an adverse
reaction reporting it), the reported data has certainly led to some interesting
conclusions.
We feel this data could be used by individuals and medical professionals to assist
in choosing a vaccine to maximize patient safety based on their allergy history, age
and gender.
This article presents an initial work that seeks to shed light on the appearance of
adverse reactions caused by different covid-19 vaccines, analyzing co-occurrences
between allergens and adverse reactions caused by these vaccines. For the next
step, it would be interesting to apply advanced data mining techniques to predict
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the level of seriousness of a potential allergic reaction in a new patient to be
vaccinated with a specific vaccine, thus helping to assess the suitability of a certain
vaccine type for each patient in terms of minimizing the probability of the
appearance of a severe allergic reaction.

REFERENCES
American College of Allergy, Asthma and Immunology. (2021, April 26). Acaai
updates to guidance on risk of allergic reactions to covid-19 vaccines. Retrieved
July 12, 2021, from https://acaai.org/news/ acaai-updates-guidance-risk-allergicreactions-covid-19-vaccines
Blumenthal, K., Robinson, L., Camargo, C., Shenoy, E., Banerji, A., Landman,
A., & Wickner, P. (2021). Acute allergic reactions to mrna covid-19 vaccines.
Journal of the American Medical Association, 325, 1562–1565.
Brown, S. G., & Turner, P. J. (2015). Anaphylaxis. In R. O’Hehir, S. Holgate, &
A. Sheikh (Eds.), Middleton’s allergy essentials first edition (pp. 345–360).
Centers for Disease Control and Prevention. (2021, June 20). Understanding
adverse events and side effects. Retrieved June 28, 2021, from https:
//www.cdc.gov/vaccinesafety/ensuringsafety/sideeffects/index.html
HealthLine. (2020, December 16). What are environmental allergies? Retrieved
May 31, 2021, from https://www.healthline.com/health/ allergies/environmentalallergies
Levin, M. (2018). Allergy Terminology: Toward a Common Language and
Shared Understanding. Journal of Allergy and Clinical Immunology, 141, 1133–
1135.
Mayo Clinic. (2021, June 25). What are the vaccines’ side effects? Retrieved
June 28, 2021, from https://www.mayoclinic.org/coronavirus-covid-19/vaccineside-effects

©International Information Management Association, Inc. 2021

.

39

Covid - 19 - Vaccine Allergic Reactions

Schumaker - Veronin - Rohm - Dixit - Aljawarneh - Lara

Rendall, J. (2021, July 12). Johnson & johnson vaccine linked to rare cases of
autoimmune disorder. Retrieved July 13, 2021, from https://www.
cnet.com/health/johnson-johnson-vaccine-linked-to-rare-cases-ofautoimmunedisorder/
Shimabukuro, T., Nguyen, M., Martin, D., & DeStefano, F. (2015). Safety
monitoring in the vaccine adverse event reporting system (vaers).Vaccine, 33,
4398–4405.
Singleton, J., Lloyd, J., Mootrey, G., Salive, M., & Chen, R. (1999). An
overview of the vaccine adverse event reporting system (vaers) as a surveillance
system. Vaccine, 17, 2908–2017.
Tang, M. L. K., & Mullins, R. J. (2017). Food allergy: Is Prevalence Increasing?
Internal Medicine Journal, 47, 256–261.
The Daily Meal. (2012, February 8). The 10 most common food allergies.
Retrieved May 31, 2021, from https://www.thedailymeal.com/10most-commonfood-allergies-0
Varricchio, F., Iskander, J., DeStefano, F., Ball, R., Pless, R., Braun, M., & Chen,
R. (2004). Understanding vaccine safety information from the vaccine adverse
event reporting system. Pediatric Infectious Disease Journal, 23, 287–294.
Veronin, M., Lang, A., & Reinert, J. (2021). Remdesivir and coronavirus disease
2019 (covid-19): Essential questions and answers for pharmacists and pharmacy
technicians. Journal of Pharmacy Technology, 37, 62–74.
WebMD. (2021, May 31). Common drugs that cause allergies. Retrieved May
31, 2021, from https://www.webmd.com/allergies/most-commondrugs-thatcause-allergies

©International Information Management Association, Inc. 2021

.

40

